SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001048477-02-000020
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
10
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 BIOMARIN 10-K financialsandnotes2002.txt 10-K 243300
3 GBL ACQUISITION AGREEMENT exhibit_2-5.txt EX-2 229324
4 AMENDMENT AND RESTATEMENT OF THE BY-LAWS biomaringeneralbylawsv2.txt EX-3 57219
5 AMENDMENT TO BMK LEASE exhibit_10-18.txt EX-10 3828
6 AMENDMENT TO GALLI LEASE exhibit_10-20.txt EX-10 21253
7 79 DIGITAL LEASE exhibit_10-22.txt EX-10 125291
8 SYNAPSE ACQUISITION AGREEMENT exhibit_10-26.txt EX-10 180340
9 BIOMARIN EXHIBIT 21.1 LIST OF SUBSIDIARIES exhibit211listofsubs.txt EX-21 1528
10 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS consent032802.txt EX-23 667
11 EXHIBIT 99.1 lettertosec1bmrn.txt EX-99 1137
  Complete submission text file 0001048477-02-000020.txt   866585
Mailing Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949
Business Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949 4158846700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26727 | Film No.: 02597560
SIC: 2834 Pharmaceutical Preparations